메뉴 건너뛰기




Volumn 14, Issue 6, 2012, Pages 668-675

Rationale and design of ARTS: A randomized, double-blind study of BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease

Author keywords

Aldosterone; Antagonist; Chronic kidney disease; Heart failure; Mineralocorticoid receptor

Indexed keywords

ANDROGEN RECEPTOR; BAY 948862; EPLERENONE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLUCOCORTICOID RECEPTOR; HORMONE RECEPTOR BLOCKING AGENT; MINERALOCORTICOID RECEPTOR; PLACEBO; POTASSIUM; PROGESTERONE RECEPTOR; SPIRONOLACTONE; UNCLASSIFIED DRUG;

EID: 84861563400     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfs061     Document Type: Article
Times cited : (80)

References (29)
  • 2
    • 80051990993 scopus 로고    scopus 로고
    • CONSENSUS to EMPHASIS: The overwhelming evidence which makes blockade of the renin-angiotensin-aldosterone system the cornerstone of therapy for systolic heart failure
    • McMurray JJ. CONSENSUS to EMPHASIS: the overwhelming evidence which makes blockade of the renin-angiotensin-aldosterone system the cornerstone of therapy for systolic heart failure. Eur J Heart Fail 2011;13:929-936.
    • (2011) Eur J Heart Fail , vol.13 , pp. 929-936
    • McMurray, J.J.1
  • 4
    • 0033517302 scopus 로고    scopus 로고
    • The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators
    • Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-717.
    • (1999) N Engl J Med , vol.341 , pp. 709-717
    • Pitt, B.1    Zannad, F.2    Remme, W.J.3    Cody, R.4    Castaigne, A.5    Perez, A.6    Palensky, J.7    Wittes, J.8
  • 7
    • 80052529403 scopus 로고    scopus 로고
    • Aldosterone blockers (mineralocorticoid receptor antagonism) and potassium-sparing diuretics
    • Epstein M, Calhoun DA. Aldosterone blockers (mineralocorticoid receptor antagonism) and potassium-sparing diuretics. J Clin Hypertens (Greenwich) 2011;13: 644-648.
    • (2011) J Clin Hypertens (Greenwich) , vol.13 , pp. 644-648
    • Epstein, M.1    Calhoun, D.A.2
  • 8
    • 33845302661 scopus 로고    scopus 로고
    • Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease
    • Bianchi S, Bigazzi R, Campese VM. Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease. Kidney Int 2006;70:2116-2123.
    • (2006) Kidney Int , vol.70 , pp. 2116-2123
    • Bianchi, S.1    Bigazzi, R.2    Campese, V.M.3
  • 9
    • 38149030811 scopus 로고    scopus 로고
    • Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: A systematic review
    • Bomback AS, Kshirsagar AV, Amamoo MA, Klemmer PJ. Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: a systematic review. Am J Kidney Dis 2008;51:199-211.
    • (2008) Am J Kidney Dis , vol.51 , pp. 199-211
    • Bomback, A.S.1    Kshirsagar, A.V.2    Amamoo, M.A.3    Klemmer, P.J.4
  • 10
    • 73349142401 scopus 로고    scopus 로고
    • Mineralocorticoid receptor blockers and chronic kidney disease
    • Jain G, Campbell RC, Warnock DG. Mineralocorticoid receptor blockers and chronic kidney disease. Clin J Am Soc Nephrol 2009;4:1685-1691.
    • (2009) Clin J Am Soc Nephrol , vol.4 , pp. 1685-1691
    • Jain, G.1    Campbell, R.C.2    Warnock, D.G.3
  • 17
    • 0035818917 scopus 로고    scopus 로고
    • Aldosterone in congestive heart failure
    • Weber KT. Aldosterone in congestive heart failure. N Engl J Med 2001;345: 1689-1697.
    • (2001) N Engl J Med , vol.345 , pp. 1689-1697
    • Weber, K.T.1
  • 19
    • 0035997359 scopus 로고    scopus 로고
    • Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension
    • Weinberger MH, Roniker B, Krause SL, Weiss RJ. Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension. Am J Hypertens 2002;15: 709-716.
    • (2002) Am J Hypertens , vol.15 , pp. 709-716
    • Weinberger, M.H.1    Roniker, B.2    Krause, S.L.3    Weiss, R.J.4
  • 21
    • 33748637106 scopus 로고    scopus 로고
    • Mineralocorticoid-receptor blockade, hypertension and heart failure
    • Funder JW. Mineralocorticoid-receptor blockade, hypertension and heart failure. Nat Clin Pract Endocrinol Metab 2005;1:4-5.
    • (2005) Nat Clin Pract Endocrinol Metab , vol.1 , pp. 4-5
    • Funder, J.W.1
  • 22
    • 84856337738 scopus 로고    scopus 로고
    • Molecular pharmacology of the mineralocorticoid receptor: Prospects for novel therapeutics
    • Kolkhof P, Borden SA. Molecular pharmacology of the mineralocorticoid receptor: prospects for novel therapeutics. Mol Cell Endocrinol 2012;350:310-317.
    • (2012) Mol Cell Endocrinol , vol.350 , pp. 310-317
    • Kolkhof, P.1    Borden, S.A.2
  • 23
    • 80755126650 scopus 로고    scopus 로고
    • Mineralocorticoid receptor antagonism: Therapeutic potential in acute heart failure syndromes
    • Albaghdadi M, Gheorghiade M, Pitt B. Mineralocorticoid receptor antagonism: therapeutic potential in acute heart failure syndromes. Eur Heart J 2011;32: 2626-2633.
    • (2011) Eur Heart J , vol.32 , pp. 2626-2633
    • Albaghdadi, M.1    Gheorghiade, M.2    Pitt, B.3
  • 24
    • 0033574249 scopus 로고    scopus 로고
    • A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group
    • Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-170.
    • (1999) Ann Intern Med , vol.130 , pp. 461-170
    • Levey, A.S.1    Bosch, J.P.2    Lewis, J.B.3    Greene, T.4    Rogers, N.5    Roth, D.6
  • 28
    • 39749199510 scopus 로고    scopus 로고
    • A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity
    • Dietz JD, Du S, Bolten CW, Payne MA, Xia C, Blinn JR, Funder JW, Hu X. A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity. Hypertension 2008;51:742-748.
    • (2008) Hypertension , vol.51 , pp. 742-748
    • Dietz, J.D.1    Du, S.2    Bolten, C.W.3    Payne, M.A.4    Xia, C.5    Blinn, J.R.6    Funder, J.W.7    Hu, X.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.